Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study

NCT04718792 is registered in ClinicalTrials.gov with Anders Fink-Jensen, MD, DMSci as lead sponsor.

NCT NCT04718792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04718792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Lead sponsor
Anders Fink-Jensen, MD, DMSci
Phase
Phase 2
Overall status
Unknown status
Start date
February 9, 2023
Completion date
July 21, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)